UPDATE: Wunderlich Initiates Conceptus at Hold

Wunderlich is out with its report today on Conceptus CPTS, initiating CPTS at Hold. In a note to clients, Wunderlich writes, "We are initiating coverage of Conceptus, Inc. with a Hold rating and a $14 price target on the shares. CPTS is the leading player in the minimally invasive, transcervical sterilization market. The company's Essure implant offers women a highly effective, minimally invasive option for permanent birth control, which can be performed quickly in a doctor's office." At the time of posting, shares of CPTS were trading at $12.25, down 1.05% from Thursday's close.